Showing results (51-60 of 409) with videos related to

Sort By:
Pageof 41
Systems Biology in Reproductive Medicine|November 8, 2011
Influence of sampling factors on canine sperm motility parameters measured by the Sperm Class AnalyzerJ Dorado, T Rijsselaere, A Muñoz-Serrano, et al.
Analytical and Bioanalytical Chemistry|February 1, 1996
Trace enrichment and measurement of platinum by flow injection inductively coupled plasma mass spectrometryM M Hidalgo, M M Gómez, M A Palacios
Anatomy and Embryology|May 29, 2004
Spatial and temporal patterns of apoptosis during differentiation of the retina in the turtleJ Francisco-Morcillo, M Hidalgo-Sánchez, G Martín-Partido
Archives of Virology|January 1, 1991
Identification in porcine faeces of a novel virus with a bisegmented double stranded RNA genomeJ E Ludert, M Hidalgo, F Gil, et al.
Rapid Communications in Mass Spectrometry : RCM|September 28, 2010
Characterisation of alkylamine ethoxylates (ANEOs) in commercial herbicide formulations using liquid chromatography/electrospray ionisation mass spectrometryM Corbera, B M Simonet, V Salvadó, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|January 15, 2016
Effect of elastic colored noise in the hopping dynamics of single molecules in stretching experimentsM Hidalgo-Soria, A Pérez-Madrid, I Santamaría-Holek
Anticancer Research|April 22, 2011
Synergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell linesJ L Spratlin, T M Pitts, G N Kulikowski, et al.
Investigational New Drugs|December 16, 1998
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming unitsL L Siu, D D Von Hoff, A Rephaeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignanciesS G Eckhardt, S D Baker, C D Britten, et al.
British Journal of Cancer|October 29, 2011
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumoursY Pan, R Xu, M Peach, et al.
Pageof 41